Literature DB >> 22651253

HLA DNA typing: past, present, and future.

H Erlich1.   

Abstract

The human leukocyte antigen (HLA) class I and class II loci are the most polymorphic genes in the human genome, with a highly clustered and patchwork pattern of sequence motifs. In the three decades since the first HLA gene was isolated by molecular cloning (a cDNA clone of HLA-B7), thousands of alleles have been identified and the names and sequences of all known alleles have been curated in the IMGT/HLA database. This extensive allelic diversity made and continues to make high-resolution HLA DNA typing very challenging. The first attempt at HLA DNA typing involved restriction fragment length polymorphism (RFLP) analysis, but this approach had many limitations. The development of PCR in 1985 allowed for the amplification of the polymorphic exons of the HLA class I and class II genes and the analysis of the polymorphic sequence motifs with sequence-specific oligonucleotide (SSO) hybridization probes. The immobilization of these probes on membranes and later on beads, along with primer sets for sequence-specific priming (SSP), gave rise to the current set of HLA typing reagents. Sanger sequencing has provided high-resolution typing but, in many cases, genotyping 'ambiguity' remains an issue. In the past few years, the introduction of next-generation sequencing, with the critical properties of massively parallel and clonal sequencing, has significantly reduced HLA genotyping ambiguity. Here, our lab's efforts to develop high-resolution and high-throughput HLA DNA typing using the 454 Sequencing System are reviewed, and the potential future developments and applications of HLA DNA typing are discussed.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22651253     DOI: 10.1111/j.1399-0039.2012.01881.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  72 in total

1.  Histoimmunogenetics Markup Language 1.0: Reporting next generation sequencing-based HLA and KIR genotyping.

Authors:  Robert P Milius; Michael Heuer; Daniel Valiga; Kathryn J Doroschak; Caleb J Kennedy; Yung-Tsi Bolon; Joel Schneider; Jane Pollack; Hwa Ran Kim; Nezih Cereb; Jill A Hollenbach; Steven J Mack; Martin Maiers
Journal:  Hum Immunol       Date:  2015-08-28       Impact factor: 2.850

2.  Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing.

Authors:  Steven J Mack; Robert P Milius; Benjamin D Gifford; Jürgen Sauter; Jan Hofmann; Kazutoyo Osoegawa; James Robinson; Mathijs Groeneweg; Gregory S Turenchalk; Alex Adai; Cherie Holcomb; Erik H Rozemuller; Maarten T Penning; Michael L Heuer; Chunlin Wang; Marc L Salit; Alexander H Schmidt; Peter R Parham; Carlheinz Müller; Tim Hague; Gottfried Fischer; Marcelo Fernandez-Viňa; Jill A Hollenbach; Paul J Norman; Martin Maiers
Journal:  Hum Immunol       Date:  2015-09-25       Impact factor: 2.850

3.  Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing.

Authors:  Shengli Song; Miaomiao Han; Han Zhang; Yuanxia Wang; Hong Jiang
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

4.  Accurate Typing of Human Leukocyte Antigen Class I Genes by Oxford Nanopore Sequencing.

Authors:  Chang Liu; Fangzhou Xiao; Jessica Hoisington-Lopez; Kathrin Lang; Philipp Quenzel; Brian Duffy; Robi D Mitra
Journal:  J Mol Diagn       Date:  2018-04-03       Impact factor: 5.568

5.  DNA storage under high temperature conditions does not affect performance in human leukocyte antigen genotyping via next-generation sequencing (DNA integrity maintained in extreme conditions).

Authors:  Shana L McDevitt; Michael E Hogan; Derek J Pappas; Lily Y Wong; Janelle A Noble
Journal:  Biopreserv Biobank       Date:  2014-12       Impact factor: 2.300

6.  Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest.

Authors:  D J Pappas; A Lizee; V Paunic; K R Beutner; A Motyer; D Vukcevic; S Leslie; J Biesiada; J Meller; K D Taylor; X Zheng; L P Zhao; P-A Gourraud; J A Hollenbach; S J Mack; M Maiers
Journal:  Pharmacogenomics J       Date:  2017-04-25       Impact factor: 3.550

7.  Revisiting the potential power of human leukocyte antigen (HLA) genes on relationship testing by massively parallel sequencing-based HLA typing in an extended family.

Authors:  Riga Wu; Haixia Li; Dan Peng; Ran Li; Yinming Zhang; Bo Hao; Erwen Huang; Chenghao Zheng; Hongyu Sun
Journal:  J Hum Genet       Date:  2018-10-22       Impact factor: 3.172

Review 8.  Next-generation sequencing diagnostics for neurological diseases/disorders: from a clinical perspective.

Authors:  Jia Nee Foo; Jianjun Liu; Eng-King Tan
Journal:  Hum Genet       Date:  2013-03-23       Impact factor: 4.132

9.  PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Authors:  Julia M Barbarino; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2015-04       Impact factor: 2.089

10.  HLA polymorphism and risk of multiple myeloma.

Authors:  Meral Beksac; Loren Gragert; Stephanie Fingerson; Martin Maiers; Mei-Jie Zhang; Mark Albrecht; Xiaobo Zhong; Wendy Cozen; Angela Dispenzieri; Sagar Lonial; Parameswaran Hari
Journal:  Leukemia       Date:  2016-07-27       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.